Products

What will AGI do for Betamethasone dihydrogen phosphate?

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H30FO8P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YJO1F9W10R, chemically known as pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, (11.beta.,16.beta.)-, but more generally known as betamethasone dihydrogen phosphate, which bears US NIH Compound Identifier 107782. European Medicines Agency schedules betamethasone dihydrogen phosphate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05797MIG. Most nations, for tariff purposes, schedule betamethasone dihydrogen phosphate under HS 29372200. As of Q4 2014, BETAMETHASONE DIHYDROGEN PHOSPHATE remains US FDA's Preferred Term for this commodity. Betamethasone dihydrogen phosphate bears US NLM identifiers UMLS ID C2698382 and NCI Concept Code C77406. SMILES: C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)(O)O)O)C)O)F)C.